Immunitybio, Inc. Securities Fraud Class Action Result Of FDA Warning And 21% Stock Decline - Investors May Contact Lewis Kahn, Esq, At Kahn Swick & Foti, LLC
Хамгийн сүүлийн үеийн мэдээ, гарчиг
(MENAFN - GlobeNewsWire - Nasdaq) Who is Involved: ImmunityBio, Inc. (NasdaqGS: IBRX) investors that purchased between January 19, 2026 and ...
Мэдээ